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Fetal death after 20 weeks of gestation in combina-
tion with complete placenta previa is rarely seen. A
search in PubMed and EMBASE (1966–2006;
search terms: ‘placenta previa’ and ‘fetal death’)
revealed only one case report [1]. There is limited
experience with these cases and management is
controversial. An inquiry among the eight University
Hospitals in the Netherlands revealed only three
cases in the period of 1990 through 2005. These
cases, in which three different policies were followed,
are presented below.
The first woman was a 33-year-old gravida 7 para
4, with a well-controlled diabetes mellitus. She had
had four uncomplicated deliveries and two miscar-
riages. The pregnancy in question, in 1990, was
complicated by complete placenta previa. Fetal death
occurred unexpectedly at 33 weeks. There was no
bleeding. Five days later labor induction was
initiated using prostaglandins (intravenous sulpros-
tone, intramuscular carboprost and intracervical
dinoprostone, respectively). After eight days and a
total administration of 17 000 mg prostaglandins,
attempts to induce labor were discontinued because
of minimal cervical response. Expectant manage-
ment was now agreed upon. Nineteen days after the
diagnosis of stillbirth, the woman was readmitted
because of fever and ruptured membranes. Coagula-
tion tests and hemoglobin were normal and bleeding
was still minimal. Antibiotics and oxytocin were
started intravenously. Fourteen hours after admis-
sion the patient gave birth to a stillborn son with
a birth weight of 1070 g (55th percentile).
The placenta had to be extracted manually and
weighed 130 g (510th percentile). A central placen-
tal rupture was present, suggesting that the fetus was
born through the placenta. Total blood loss was
50 mL and the postpartum period was uneventful.
The second case was a 33-year-old woman, who
was gravida 5 para 2. Her two previous children were
born by cesarean section because of cephalopelvic
disproportion. In 1998 at 26þ5 weeks she com-
plained of painless vaginal bleeding. Ultrasound
examination showed complete placenta previa with
partial placental abruption and fetal death in
transverse lie. Blood loss was moderate and coagula-
tion tests and hemoglobin were normal. Contrac-
tions started and ultrasound examination showed
cervical dilation of 1 cm. After ample consideration
it was decided to perform a repeat cesarean section,
because of the risk of uterine rupture and the explicit
request of the mother who wished to try for another
child in the future. A stillborn boy of 680 g (10–50th
percentile) was delivered. The placenta weighed
165 g (510th percentile). The cesarean section was
complicated by a hemorrhage of 1500 mL for which
two units of packed cells, two units of fresh frozen
plasma and sulprostone were administered intrave-
nously. The postoperative period was uneventful
with normal coagulation tests.
The third woman was a 37-year-old gravida 4 para
2. Her obstetric history revealed two uncomplicated
pregnancies and one spontaneous abortion. In 2000
at 20 weeks of gestation, she was referred because of
moderate painless vaginal bleeding. Ultrasound
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showed complete placenta previa and a living fetus.
There was normal fetal growth without signs of fetal
distress and vaginal bleeding remained scarce. At 23
weeks, however, the patient was admitted because of
increased vaginal bleeding and fetal death was
diagnosed. She was hemodynamically stable. Be-
cause blood loss decreased it was decided, after
ample consideration of all therapeutic options, to
manage the case expectantly. Two weeks later, at 25
weeks of gestation, the woman suffered from
moderate bleeding and subsequently went into labor.
Blood tests showed normal coagulation and hemo-
globin. After three hours the placenta was located in
the vagina and could easily be removed. The fetus
was extracted under general anesthesia. A child of
470 g (10–50th percentile) and a placenta of 95 g
(510th percentile) were delivered. Total blood
loss was 100 mL and the postpartum period was
uneventful.
In this report, we present three cases in which
induction of labor, cesarean section and expectant
management were performed, respectively, in case of
second- and third-trimester fetal death complicated
by complete placenta previa. These cases illustrate
that postponing delivery, aiming at vaginal birth, is a
feasible option.
There are important arguments in favor of primary
expectant management. First, some of the women
with fetal death will deliver spontaneously during the
waiting period (75–90% within two weeks, without
placenta previa) [2]. Secondly, the placenta will
become atrophic in time, which will probably result
in less total bleeding. Indeed, in the first and third
case the period between fetal death and labor was
considerable with very little blood loss, possibly due
to placental atrophy. In a small retrospective study of
15 patients with complete placenta previa, Ruano
et al. showed that feticide two to 14 days before
therapeutic pregnancy termination (gestational age
18–31 weeks) reduces blood loss [3]. The final
argument in favor of primary expectant management
is that placental atrophy will simplify vaginal delivery
and dilation and evacuation (D&E) because the
placenta will no longer impose an important ob-
struction. Fetal maceration and shrinking will also
simplify D&E, if this should be necessary [4]. In
conclusion, introducing an expectant period will
probably reduce the number of complications
associated with delivery in these patients.
Expectant management, however, may have dis-
advantages. Coagulation changes may occur,
although these rarely develop within one month after
fetal demise [5]. It is also likely that the risk of
intrauterine infection will increase in time. Further-
more, the continued carrying of a dead fetus might
increase psychological stress [6]. On the other hand,
a period between diagnosis of fetal death and
pregnancy termination can improve a woman’s
ability to cope with the tragedy and prepare her for
termination. Of course, the optimal duration for this
is highly dependent on personal and cultural
circumstances.
Based on the literature and our experience, we
would advise an expectant period of about two weeks
after the occurrence of fetal death. After two weeks
placental atrophy will be substantial, the chance of
spontaneous labor will probably be low, and the risk
of coagulation changes and especially infection will
only increase. In this period serious attention should
be given to psychological support.
If a patient has not delivered within two weeks, or
if an earlier termination is indicated, we would
recommend medical induction. Prostaglandins can
be used to induce labor, but misoprostol, alone or in
combination with mifepristone, is just as effective
[1,7].
In our opinion, surgical termination should be the
last option. The first procedure that can be con-
sidered is D&E. Skilled surgeons can safely perform
this procedure until about 24 weeks, also in the case
of placenta previa [4,8,9]. There is currently,
however, only limited experience with second-
trimester D&E among obstetricians in the Nether-
lands. If D&E is performed in the case of fetal death
one should beware of coagulopathy, which can
develop by release of placental tissue, thromboplastin
and amniotic fluid into the maternal circulation
[4,10]. We feel that an important disadvantage of
mechanical destruction in the case of fetal death is
that parents will not be able to see and hold their
infant. This could easily hamper bereavement,
especially if this is not the parents’ own choice. Data
on this are, however, not conclusive and well-
controlled trials comparing medical induction and
D&E are lacking for second-trimester pregnancy
termination [6,11,12].
The second surgical option is cesarean section.
Besides the risk of operative morbidity and mortality,
a cesarean section increases the risk of placental
abnormalities such as placenta accreta and placenta
previa and the risk of uterine rupture in subsequent
pregnancies [13,14].
The mode of pregnancy termination in women
with a uterine scar is controversial because these
women have a higher risk of uterine rupture than
those without a scar in the case of medical induction
(3.8 versus 0.2%) [15]. Therefore, in the case of a
uterine scar careful consideration of the risks is
necessary before making a decision.
In the cases described in this report, expectant
management in order to achieve vaginal birth showed
a favorable outcome. In the case in which postponing
delivery was not an option, since labor had started
with the fetus in transverse lie, blood loss during the
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cesarean section was limited to 1.5 L. If complete
placenta previa is complicated by fetal death, we
believe that delayed vaginal delivery should be
considered to minimize the risk of complications.
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